ECC: Everolimus Effective in Advanced Papillary Renal Cell Carcinoma

The mTOR inhibitor everolimus showed clinical efficacy for the initial treatment of advanced papillary renal cell carcinoma, according to the phase II results of the RAPTOR trial.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news